We are happy to announce today the opening of a Security Token Offering (STO) on the EDSX platform, after raising a record €2M on Capital cell. Capital Cell is the the 1st European platform for participative financing dedicated to healthcare. We have raised 2 millions euros in less than 24h! Read more…
Emergence of 3D cell culture in cell biology represents a new area of cellular culture technology. Here at HCS Pharma, we are developing innovative 3D cells models for high content analysis.
marketreports.com publish a report on hts development and potential market in 3 next years. This market report summarizes the results of HTStec’s global web-based benchmarking survey on high throughput screening (HTS) metrics and future directions carried out in July 2014 … Curated from marketreports.com